Intrauterine Growth Restriction (IUGR) - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Intrauterine Growth Restriction (IUGR) – Comprehensive Medical Guide

Intrauterine Growth Restriction (IUGR)

Overview

Intrauterine growth restriction (IUGR), also called fetal growth restriction (FGR), is a condition in which a fetus does not reach its genetically predetermined growth potential. Instead of the normal growth curve, the fetal weight falls below the 10th percentile for gestational age, or the abdominal circumference is < 2.5th percentile.

Although the term “IUGR” is often used interchangeably with “small for gestational age (SGA),” the two are not identical. SGA simply describes a baby who is small at birth, while IUGR implies an underlying pathological process that has limited growth.

Who it affects

  • Pregnant people of any age, ethnicity, or socioeconomic status.
  • It is slightly more common in low‑ and middle‑income countries, where maternal malnutrition and infections are prevalent.
  • Women with pre‑existing medical conditions (e.g., hypertension, diabetes) or obstetric complications have a higher risk.

Prevalence

Globally, IUGR affects approximately 5–10 % of all pregnancies. In the United States, the CDC estimates that about 7 % of live births are classified as SGA, and roughly half of these meet criteria for IUGR.[1] CDC, 2022 In low‑resource settings, prevalence can rise to 15 % or more.[2] WHO, 2020

Symptoms

Because the fetus is inside the uterus, the mother rarely feels “symptoms” of IUGR directly. However, clinicians may notice indirect signs during prenatal care.

  • Decreased fetal movement – A noticeable reduction in the number or vigor of kicks after the 28‑week mark.
  • Abnormal fundal height – The uterus measures smaller than expected for gestational age.
  • Maternal perception of “small baby” – Some women report that their baby feels “tiny” during a routine exam.
  • Ultrasound findings:
    • Fetal abdominal circumference < 10th percentile.
    • Discrepancy between head and abdominal measurements (head‑sparing pattern).
    • Doppler abnormalities (elevated resistance in uterine or umbilical arteries).

Remember, many of these findings are detected only by a health‑care professional during scheduled visits.

Causes and Risk Factors

IUGR is usually multifactorial. The primary categories are maternal, placental, fetal, and environmental factors.

Maternal causes

  • Chronic hypertension or pre‑eclampsia – Reduces uteroplacental blood flow.
  • Diabetes mellitus – Poorly controlled can lead to vascular disease and placental insufficiency.
  • Autoimmune diseases (e.g., systemic lupus erythematosus, antiphospholipid syndrome).
  • Malnutrition or anemia – Low protein or iron intake limits fetal growth.
  • Substance use – Smoking (increases risk 2–3×), alcohol, cocaine, and illicit drugs.
  • Infections – TORCH infections (Toxoplasmosis, Rubella, CMV, Herpes), syphilis, malaria, HIV.
  • Uterine abnormalities – Bicornuate uterus, fibroids that distort the cavity.

Placental causes

  • Placental insufficiency due to poor trophoblastic invasion.
  • Placental infarcts, abruption, or previa.
  • Maternal vascular malperfusion (common in hypertensive disorders).

Fetal causes

  • Chromosomal abnormalities (e.g., trisomy 21, trisomy 18).
  • Congenital infections (CMV, rubella).
  • Structural anomalies (renal agenesis, cardiac defects).
  • Multiple gestations – Twins or higher order pregnancies share limited placental resources.

Risk factors summary

  • Maternal age < 20 or > 35 years.
  • Previous pregnancy with IUGR or stillbirth.
  • Low pre‑pregnancy BMI (< 18.5 kg/m²) or obesity (BMI > 30 kg/m²).
  • Socio‑economic deprivation and limited access to prenatal care.
  • Living at high altitude (> 2,500 m) due to lower oxygen pressure.

Diagnosis

Diagnosis hinges on serial assessment of fetal growth and placental function.

Clinical evaluation

  • History & physical – Review of maternal illnesses, medication use, lifestyle, and prior obstetric outcomes.
  • Fundal height measurement – Discrepancy > 2 cm from expected size after 20 weeks prompts further work‑up.

Ultrasound

  1. Biometry – Head circumference (HC), abdominal circumference (AC), femur length (FL). AC < 10th percentile is the most sensitive marker.
  2. Doppler velocimetry – Evaluates blood flow in:
    • Umbilical artery (UA) – Elevated resistance index suggests placental insufficiency.
    • Middle cerebral artery (MCA) – “Brain‑sparing” increased flow may appear as a compensatory mechanism.
    • Uterine arteries (UtA) – High resistance early in pregnancy can predict later IUGR.
  3. Amniotic fluid volume – Low volume (oligohydramnios) often co‑exists with IUGR.

Additional tests

  • Maternal blood work – CBC, glucose tolerance test, hemoglobin A1c, TORCH serologies, syphilis (RPR), HIV screening.
  • Placental pathology (post‑delivery) – Helps identify vascular lesions or infection.
  • Fetal surveillance – Non‑stress test (NST) and biophysical profile (BPP) to assess fetal well‑being.

Treatment Options

There is no “cure” for IUGR; management focuses on optimizing the intrauterine environment, close monitoring, and deciding the safest timing of delivery.

Medical management

  • Control maternal hypertension – First‑line agents such as labetalol, nifedipine, or methyldopa. Goal: keep blood pressure < 140/90 mmHg.
  • Gestational diabetes treatment – Dietary modification, glucose monitoring, insulin if needed.
  • Aspirin prophylaxis – Low‑dose (81 mg) aspirin started before 16 weeks reduces risk of pre‑eclampsia‑related IUGR.[3] ACOG, 2023
  • Smoking cessation programs – Counseling, nicotine replacement (if approved), or behavioral support.

Procedural/interventional options

  • Maternal oxygen therapy – Short‑term (30 min) administration of 40 % FiO₂ may transiently improve fetal oxygenation, but evidence is limited.
  • Bed rest & activity modification – Historically recommended, but recent studies show minimal benefit; still considered for severe cases when uterine blood flow may be compromised.
  • Delivery – The definitive treatment. Timing depends on gestational age, severity, and fetal status:
    • Early preterm (< 32 weeks): If Doppler shows worsening (absent/reversed end‑diastolic flow) or NST/BPP abnormal, delivery via corticosteroid‑enhanced pre‑term birth may be indicated.
    • Late preterm (34‑36 weeks) or term: Delivery is usually recommended once fetal compromise is documented.

Lifestyle & supportive measures

  • Balanced, high‑protein diet with adequate calories (approx. 300‑500 kcal extra after 20 weeks for at‑risk women).
  • Prenatal vitamins with iron, folic acid, and DHA.
  • Regular, moderate‑intensity exercise (e.g., walking) unless contraindicated.

Living with Intrauterine Growth Restriction (IUGR)

For families navigating an IUGR pregnancy, day‑to‑day strategies can reduce stress and improve outcomes.

Monitoring at home

  • Track fetal movements daily from 28 weeks onward; count 10 movements within 2 hours.
  • Maintain a log of prenatal appointments, ultrasound dates, and any symptoms (e.g., headaches, vision changes).

Nutrition & hydration

  • Eat small, frequent meals rich in lean protein, whole grains, fruits, and vegetables.
  • Stay hydrated – aim for 2‑3 L of fluid daily unless restricted by a medical condition.

Emotional wellbeing

  • Join a support group (online or in‑person) for high‑risk pregnancies.
  • Practice stress‑reduction techniques such as deep breathing, prenatal yoga, or mindfulness.
  • Talk openly with your obstetric team about concerns; clear communication reduces anxiety.

Preparation for possible early delivery

  • Tour the neonatal intensive care unit (NICU) if your hospital has one.
  • Gather essential items for a NICU stay (e.g., baby clothing, breastfeeding supplies, insurance paperwork).
  • Discuss with your pediatrician about follow‑up care for a growth‑restricted infant.

Prevention

While not all cases are preventable, many risk factors are modifiable.

  • Pre‑conception care – Optimize weight, control chronic conditions, and review medications.
  • Early prenatal care – First‑trimester ultrasound and blood work identify risk early.
  • Smoking & substance avoidance – Complete cessation before conception is ideal.
  • Vaccination – Rubella, influenza, and hepatitis B immunizations reduce infection‑related IUGR.
  • Nutrition – Adequate folic acid (400 µg daily) and iron supplementation reduce anemia‑related growth restriction.
  • Low‑dose aspirin for women with prior pre‑eclampsia, hypertension, or known risk per ACOG guidelines.[3] ACOG, 2023

Complications

If IUGR is not recognized or managed, both short‑ and long‑term complications can arise.

Neonatal complications

  • Pre‑term birth and associated respiratory distress syndrome.
  • Hypoglycemia due to limited glycogen stores.
  • Hypothermia – smaller surface area leads to rapid heat loss.
  • Polycythemia and hyperviscosity, increasing risk of stroke.
  • Neonatal jaundice and need for phototherapy.
  • Neurodevelopmental delays, learning difficulties, and cerebral palsy (especially with severe, early‑onset IUGR).

Long‑term health risks

  • Increased risk of hypertension, type 2 diabetes, and coronary artery disease in adulthood (the “Barker hypothesis”).[4] WHO, 2021
  • Reduced adult stature and slower growth velocity.
  • Potential for chronic kidney disease due to reduced nephron number.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you experience any of the following:
  • Sudden decrease or complete loss of fetal movement (no kicks in 2 hours).
  • Severe abdominal pain, especially if accompanied by bleeding or vaginal fluid loss.
  • High blood pressure ≥ 160/110 mmHg with headaches, vision changes, or swelling.
  • Rapid weight gain (> 2 kg in 24 hours) with swelling, suggesting severe pre‑eclampsia.
  • Fever > 38°C (100.4°F) with chills – possible infection that can affect fetal growth.
  • Any signs of labor (regular contractions, water breaking) before 34 weeks.

Prompt evaluation can prevent severe fetal distress and improve outcomes.

References

  1. Centers for Disease Control and Prevention. “Small for Gestational Age Births.” 2022. https://www.cdc.gov/ncbddd/birthdefects/sga.html
  2. World Health Organization. “Maternal, newborn, child and adolescent health and nutrition: Global burden of disease.” 2020.
  3. American College of Obstetricians and Gynecologists. “Low‑Dose Aspirin Use During Pregnancy.” Committee Opinion No. 804. 2023.
  4. World Health Organization. “Developmental Origins of Health and Disease.” 2021.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References